Toward development of an implantable tissue engineered liver

Biomaterials

Volumn 17, Issue 3, 1996, Pages 365-372

  Davis, Matthew W ^a,b   Vacant, Joseph P ^b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Biodegradable polymer; Encapsulation; Hepatocyte transplantation; Implantable device; Liver tissue engineering; Microcarrier

Indexed keywords

CELLS; DISEASES; ENCAPSULATION; GENETIC ENGINEERING; IMPLANTS (SURGICAL); ORGANIC POLYMERS; PHYSIOLOGY; TRANSPLANTATION (SURGICAL);

BIODEGRADABLE POLYMER; EX VIVO GENE THERAPY; HEPATOCYTE TRANSPLANTATION; IMPLANTABLE DEVICE; LIVER; LIVER TISSUE ENGINEERING; MICROCARRIER;

TISSUE;

ALBUMIN; BILIRUBIN; POLYMER; UREA;

ARTICLE; ARTIFICIAL LIVER; BIOENGINEERING; CELL ADHESION; CELL TRANSPLANTATION; ENCAPSULATION; GENE THERAPY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030088133     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)85575-X     Document Type: Article

References (74)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-926.
2. Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease (Vol. 1). Philadelphia: W.B. Saunders Co., 1990.
3. Jones AL. Anatomy of the normal liver. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease. Philadelphia: W.B. Saunders Co., 1990: 3-29.
4. American Liver Foundation. Vital Statistics of the United States (Vol. 2, Part A). Hyattsville, MD: US Department of Health 1988.
5. Foster JH. The surgical management of primary hepatocellular carcinoma and metastatic liver cancer. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease. Philadelphia: W.B. Saunders Co., 1990: 1240-1249.
6. Friedmann T. Progress toward human gene therapy. Science 1989; 244: 1275-1281.
7. Raper SE, Wilson JM. Cell transplantation in liver-directed gene therapy. Cell Transplant 1993; 2: 381-400.
8. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
9. Grossman M, Raper SE, Kozarsky K et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet 1994; 6: 335-341.
10. Yarmush ML, Dunn JCY, Tompkins RG. Assessment of artificial liver support systems. Cell Transplant 1992; 1: 323-341.
11. Nyberg SL, Peshwa MV, Payne WD, Hu W-S, Cerra FB. Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg 1993; 166: 512-521.
12. Rozga J, Morsioni E, LePage E, Moscioni AD, Giorgio T, Demetriou AA. Isolated hepatocytes in a bioartificial liver: a single group view and experience. Biotechnol Bioengng 1994; 43: 645-653.
13. Rugstad HE, Robinson SH, Yannoni C, Tashjion AH Jr. Transfer of bilirubin uridine diphosphate-glucuronyl-transferase to enzyme-deficient rats. Science 1970; 170: 553-555.
14. Mukherjee AB, Krasner J. Induction of an enzyme in genetically deficient rats after grafting of normal liver. Science 1973; 182: 68-70.
15. Bissell DM, Choun MO. The role of extracellular matrix in normal liver. Scand J Gastroenterol 1988; 23: 1-7.
16. Mooney D, Hansen L, Vacanti J, Langer R, Farmer S, Ingber D. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol 1992; 151: 497-505.
17. Martinez-Hernandez A, Amenta PS. The hepatic extracellular matrix. II. Ontogenesis, regeneration, and cirrhosis. Virchows Archiv A Pathol Anat 1993; 423: 77-84.
18. Vroeman JPAM, Blanckaert N, Buurman WA, Heirwegh KPM, Koostra G. Treatment of enzyme deficiency by hepatocyte transplantation in rats. J Surg Res 1985; 39: 267-275.
19. Maganto P, Traber PG, Rusnell C, Dobbins WO III, Keren D, Gumucio JJ. Long-term maintenance of the adult pattern of liver-specific expression for P-450b, P-450e, albumin and α-fetoprotein genes in intrasplenically transplanted hepatocytes. Hepatology 1990; 11: 585-593.
20. Onodera K, Kasai S, Kato K, Sawa M, Mito M, Nozawa M. Effects of intrasplenic hepatocyte transplantation in rats congenitally deficient in ascorbic acid biosynthetic enzyme. Cell Transplant 1994; 3(Suppl 1): S31-S34.
21. Henne-Bruns D, Kruger U, Sumpelman D, Lierse W, Kremer B. Intraperitoneal hepatocyte transplantation: morphological results. Virchows Archiv A Pathol Anat 1991; 419: 45-50.
22. Saito S, Sakagami K, Koide N et al. Transplantation of spheroidal aggregate cultured hepatocytes into the rat spleen. Transplant Proc 1989; 21: 2374-2377.
23. Saito S, Sakagami K, Mutsuno T, Tanakaya K, Takaishi Y, Orita K. Long-term survival and proliferation of spheroidal aggregate cultured hepatocytes transplanted into the rat spleen. Transplant Proc 1992; 24: 1520-1521.
24. Sutherland DER, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery 1977; 82: 124-132.
25. Onodera K, Ebata H, Sawa M et al. Comparative effects of hepatocellular transplantation in the spleen, portal vein, or peritoneal cavity in congenitally ascorbic acid biosynthetic enzyme-deficient rats. Transplant Proc 1992; 24: 3006-3008.
26. Karrer FM, Reitz BL, Hao L, Lafferty KJ. Fluorescein labelling of murine hepatocytes for identification after intrahepatic transplantation. Transplant Proc. 1992; 24: 2820-2821.
27. Fujioka H, Hunt PJ, Rozga J et al. Carboxyfluorescein (CFSE) labelling of hepatocytes for short-term localization following intraportal transplantation. Cell Transplant 1994; 3: 397-408.
28. Demetriou AA, Whiting JF, Feldman D et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986; 233: 1190-1192.
29. Demetriou AA, Reisner A, Sanchez J, Levenson SM, Moscioni AD, Chowdhury JR. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology 1988; 8: 1006-1009.
30. Fevery J, Leroy P, Heirwegh KPM. Enzymic transfer of glucose and xylose from uridine diphosphate glucose and uridine diphosphate xylose to bilirubin by untreated and digitonin-activated preparations from rat liver. Biochem J 1972; 129: 619-633.
31. Gunn CH. Hereditary acholuric jaundice in a new mutant strain of rats. J Heredity 1938; 29: 137-139.
32. Nagase S, Shimamune K, Shimiya S. Albumin-deficient rat mutant. Science 1979; 205: 590-591.
33. Lim F, Sun AM. Microencapsulated islets as a bioartificial endocrine pancreas. Science 1980; 210: 908-910.
34. Sun AM, O'Shea GM. Microencapsulation of living cells in a long-term delivery system. J Controlled Rel 1985; 2: 137-141.
35. Cai Z, Shi Z, Sherman M, Sun AM. Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology 1989; 10: 855-860.
36. Dixit V, Darvasi R, Arthur M, Brezina M, Lewin K, Gitnick G. Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology 1990; 12: 1342-1349.
37. Wong H, Chang TMS. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int J Artif Organs 1986; 9: 335-336.
38. Rosen HB, Chang J, Wnek GE, Linhardt RJ, Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials 1983; 4: 131-133.
39. Vacanti JP, Morse MA, Salzman WM, Domb AJ, Perez-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988; 23: 3-9.
40. Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti JP, Langer R. Prevascularization of porous biodegradable polymers. Biotechnol Bioengng 1993; 42: 716-723.
41. Asonuma K, Gilbert JC, Stein JE, Takeda T, Vacanti JP. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg 1992; 27: 298-301.
42. Hansen LK, Vacanti JP. Hepatocyte transplantation using artificial biodegradable polymers. In: Huffman MA, Austin R, Landes G, eds. Current Controversies in Biliary Atresia. Austin, TX: Landes: 1993, 96-106.
43. Stein JE, Gilbert JC, Hansen LK, Schloo B, Ingber D, Vacanti JP. Hepatocyte transplantation into prevascularized porous matrices. Abstract Book, 22nd Annual Meeting of the American Pediatric Surgical Association; Lake Buena Vista, FL, USA, 15-18 May 1991.
44. Reid LM, Jefferson DM. Culturing hepatocytes and other differentiated cells. Hepatology 1984; 4: 548-559.
45. Bucher NLR. Liver regeneration: an overview. J Gastroenterol Hep 1991; 6: 615-624.
46. Ingle DJ, Baker BL. Histology and regenerative capacity of liver following multiple partial hepatectomies. Proc Soc Exper Biol Med 1957; 95: 813-815.
47. 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Nat Acad Sci USA 1992; 89: 89-93.
48. Starzl TE, Porter KA, Kashiwagi N, Putnam CW. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 1975; 141: 843-858.
49. Jaffe, V, Darby H, Bishop A, Hodgson HJ. The growth of liver cells in the pancreas after intraspleic implantation: the effects of portal perfusion. Int J Exper Pathol 1991; 72: 289-299.
50. Kaufmann P-M, Sano K, Uyama S, Breuer CK, Organ GM, Vacanti JP. Heterotropic hepatocyte transplantation using three dimensional polymer matrices. Evaluation of different modalities of hepatotrophic stimulation. Transplantation (in press).
51. Starzl TE, Francavilla A, Halgrimson CG et al. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973; 137: 179-199.
52. Ricordi C, Lacy PE, Gallery MP, Park PW, Flye MW. Trophic factors from pancreatic islets in combined hepatocyte-islet allografts enhance hepatocellular survival. Surgery 1989; 105: 218-223.
53. Kamei T, Falqui L, Lacy PE, Gallery MP, Flye MW. Allogeneic islets transplanted intraportally maintain hepatic integrity following portacaval shunt in rats. Transplant Proc 1990; 22: 810-813.
54. Kaufman P-M, Sano K, Uyama S, Schloo B, Vacanti JP. Heterotopic hepatocyte transplantation using three dimensional polymers. Evaluation of the stimulatory effects by portacaval shunt or islet cell cotransplantation. Transplant Proc 1994; 26: 3342-3344.
55. Mooney DJ, Kaufman P-M, Sano K et al. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Transplantation (submitted).
56. Michalopolos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4: 176-187.
57. Michalopoulos GK, Zarnegar R. Hepatocyte growth factor. Hepatology 1992; 15: 149-155.
58. Cima LG, Ingber DE, Vacanti JP, Langer R. Hepatocyte culture on biodegradable polymeric substrates. Biotechnol Bioengng 1991; 38: 145-158.
59. Barrera DA, Zylstra E, Lansbury PT, Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine). J Am Chem Soc 1993; 115: 11010-11011.
60. Mooney DJ, Langer R, Hansen LK, Vacanti JP, Ingber DE. Induction of hepatocyte differentiation by the extracellular matrix and an RGD-containing peptide. Mater Res Soc Symp Proc 1992; 252: 199-204.
61. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263: 1149-1152.
62. Grisham JW. Cell types in long-term propagable cultures of rat liver. Ann NY Acad Sci 1990; 349: 128-137.
63. Reid LM. Stem cell biology, hormone/matrix synergies and liver differentiation. Curr Opinion Cell Biol 1990; 2: 121-130.
64. Fausto N. Hepatocyte differentiation and liver progenitor cells. Curr Opinion Cell Biol 1990; 2: 1036-1042.
65. Germain L, Noël M, Gourdeau H, Marceau N. Promotion of growth and differentiation of rat ductular oval cells in primary culture. Cancer Res 1988; 48: 368-378.
66. Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989; 49: 1541-1547.
67. Zajicek G, Oren R, Weinreb M Jr. The streaming liver. Liver 1985; 5: 293-300.
68. Sigal SH, Brill S, Fiorino AS, Reid LM. The liver as a stem cell and lineage system. Am J Physiol 1992; 263: G139-G148.
69. Sirica AE, Sattler CA, Cihla HP. Characterization of a primary bile ductular cell culture from the livers of rats during extrahepatic cholestasis. Am J Pathol 1985; 120: 67-78.
70. Braun L, Mikumo R, Fausto N. Production of hepatocellular carcinoma by oval cells: cell expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res 1989; 49: 1554-1561.
71. Grisham J, Coleman WB, Smith GJ. Isolation, culture, and transplantation of rat hepatocytic precursor (stemlike) cells. Proc Soc Exper Biol Med 1993; 204: 270-279.
72. Liang P, Pardee AB. Differential display of eukaryotic messenger RNAs by means of the polymerase chain reaction. Science 1992; 257: 967-971.
73. Bauer D, Müller H, Reich J et al. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucl Acids Res 1993; 21: 4272-4280.
74. Hakvoort TBM, Leegwater ACJ, Michiels FAM, Chamleau RAFM, Lamers WH. Identification of enriched sequences from a cDNA subtraction-hybridization procedure. Nucl Acids Res 1994; 22: 878-879.